Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 4/2022

Open Access 21-03-2022 | Long-COVID Syndrome | Review Article

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA

Authors: J. Noll, M. Reichert, M. Dietrich, J. G. Riedel, M. Hecker, W. Padberg, M. A. Weigand, A. Hecker

Published in: Langenbeck's Archives of Surgery | Issue 4/2022

Login to get access

Abstract

Since the eruption of the worldwide SARS-CoV-2 pandemic in late 2019/early 2020, multiple elective surgical interventions were postponed. Through pandemic measures, elective operation capacities were reduced in favour of intensive care treatment for critically ill SARS-CoV-2 patients. Although intermittent low-incidence infection rates allowed an increase in elective surgery, surgeons have to include long-term pulmonary and extrapulmonary complications of SARS-CoV-2 infections (especially “Long Covid”) in their perioperative management considerations and risk assessment procedures. This review summarizes recent consensus statements and recommendations regarding the timepoint for surgical intervention after SARS-CoV-2 infection released by respective German societies and professional representatives including DGC/BDC (Germany Society of Surgery/Professional Association of German Surgeons e.V.) and DGAI/BDA (Germany Society of Anesthesiology and Intensive Care Medicine/Professional Association of German Anesthesiologists e.V.) within the scope of the recent literature. The current literature reveals that patients with pre- and perioperative SARS-CoV-2 infection have a dramatically deteriorated postoperative outcome. Thereby, perioperative mortality is mainly caused by pulmonary and thromboembolic complications. Notably, perioperative mortality decreases to normal values over time depending on the duration of SARS-CoV-2 infection.
Literature
18.
go back to reference Harmer D, Gilbert M, Borman R, Clark KL (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 532(2002):107–110CrossRef Harmer D, Gilbert M, Borman R, Clark KL (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 532(2002):107–110CrossRef
20.
go back to reference Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M et al (2020) Furin: a potential therapeutic target for COVID-19. iScience 23(10):101642CrossRef Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M et al (2020) Furin: a potential therapeutic target for COVID-19. iScience 23(10):101642CrossRef
25.
go back to reference Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242CrossRef Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242CrossRef
28.
go back to reference Schilling J, Lehfeld AS, Schumacher D, Ullrich A, Diercke M (2020) Krankheitsschwere der ersten COVID19-Welle in Deutschland basierend auf Meldungen gemäß Infektionsschutzgesetz. J Health Monit 5(S11):2–20 Schilling J, Lehfeld AS, Schumacher D, Ullrich A, Diercke M (2020) Krankheitsschwere der ersten COVID19-Welle in Deutschland basierend auf Meldungen gemäß Infektionsschutzgesetz. J Health Monit 5(S11):2–20
43.
go back to reference Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC et al (2020) Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR 69(30):993–998PubMedPubMedCentral Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC et al (2020) Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR 69(30):993–998PubMedPubMedCentral
45.
go back to reference NICE (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. ISBN 978–1–4731–3943–5 NICE (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. ISBN 978–1–4731–3943–5
50.
go back to reference Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS et al (2009) Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors. Arch Intern Med 169(22):2142–2147CrossRef Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS et al (2009) Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors. Arch Intern Med 169(22):2142–2147CrossRef
51.
go back to reference Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB et al (2021) „LONG COVID”:an insight. Eur Rev Med Pharmacol Sci 25:5561–5577PubMed Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB et al (2021) „LONG COVID”:an insight. Eur Rev Med Pharmacol Sci 25:5561–5577PubMed
58.
go back to reference Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 160:809–815CrossRef Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 160:809–815CrossRef
63.
go back to reference Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38CrossRef Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38CrossRef
74.
go back to reference Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738–1742. https://doi.org/10.1111/jth.14850CrossRefPubMed Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738–1742. https://​doi.​org/​10.​1111/​jth.​14850CrossRefPubMed
76.
go back to reference Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Mølller R et al (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5):1036-1045 e9CrossRef Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Mølller R et al (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5):1036-1045 e9CrossRef
81.
go back to reference Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y et al (2020) Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 7(6):998–1002CrossRef Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y et al (2020) Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 7(6):998–1002CrossRef
84.
go back to reference Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718–724CrossRef Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718–724CrossRef
86.
go back to reference Guo Q, Zhao Y, Li J, Liu J, Yang X, Guo X et al (2021) Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe 29(2):222-235 e4CrossRef Guo Q, Zhao Y, Li J, Liu J, Yang X, Guo X et al (2021) Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe 29(2):222-235 e4CrossRef
93.
go back to reference Shijo H, Iwabuchi K, Hosoda S, Watanabe H, Nagaoka I, Sakakibara N (1997) Evaluation of neutrophil functions after experimental abdominal surgical trauma. Inflamm res 47:67–74CrossRef Shijo H, Iwabuchi K, Hosoda S, Watanabe H, Nagaoka I, Sakakibara N (1997) Evaluation of neutrophil functions after experimental abdominal surgical trauma. Inflamm res 47:67–74CrossRef
95.
go back to reference Liu J Yang X Wang H Li Z Deng H Liu J et al (2021) Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. mBio 12:e00085–21. https://doi.org/10.1128/mBio Liu J Yang X Wang H Li Z Deng H Liu J et al (2021) Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. mBio 12:e00085–21. https://​doi.​org/​10.​1128/​mBio
112.
go back to reference Cohen MM, Cameron CB (1991) Should you cancel the operation when a child has an upper respiratory tract infection? Anesth Analg 72:282–288CrossRef Cohen MM, Cameron CB (1991) Should you cancel the operation when a child has an upper respiratory tract infection? Anesth Analg 72:282–288CrossRef
113.
go back to reference Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P et al (2002) Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth 12:762–769CrossRef Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P et al (2002) Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth 12:762–769CrossRef
114.
go back to reference Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J et al (2010) Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anaesthesiol V 113(6):1338–1350CrossRef Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J et al (2010) Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anaesthesiol V 113(6):1338–1350CrossRef
128.
go back to reference Jiao G Jingyi O Xueping Q Yusheng J Yaqiong C Lianxiong Y et al (2020) A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. Apr 16:ciaa443 Jiao G Jingyi O Xueping Q Yusheng J Yaqiong C Lianxiong Y et al (2020) A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. Apr 16:ciaa443
138.
go back to reference Hajifathalian K, Sharaiha RZ, Kumar S, Krisko T, Skaf D, Ang B et al (2020) Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool. PLoS One 15(9):e0239536CrossRef Hajifathalian K, Sharaiha RZ, Kumar S, Krisko T, Skaf D, Ang B et al (2020) Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool. PLoS One 15(9):e0239536CrossRef
Metadata
Title
When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA
Authors
J. Noll
M. Reichert
M. Dietrich
J. G. Riedel
M. Hecker
W. Padberg
M. A. Weigand
A. Hecker
Publication date
21-03-2022
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 4/2022
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-022-02495-8

Other articles of this Issue 4/2022

Langenbeck's Archives of Surgery 4/2022 Go to the issue
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare